BIOCON.NS Balance Sheet

Biocon Ltd.

Balance Sheet · 8 years on file (FY2018-19 to FY2025-26) · fetched 2026-08-23 21:39

Line item	FY2018-19	FY2019-20	FY2020-21	FY2021-22	FY2022-23	FY2023-24	FY2024-25	FY2025-26	Source (XBRL element)
Property, Plant and Equipment	N/A	N/A	N/A	N/A	₹75.35 Bn	₹74.18 Bn	₹87.08 Bn	₹94.73 Bn	PropertyPlantAndEquipment
Capital Work-in-Progress	N/A	N/A	N/A	N/A	₹25.88 Bn	₹39.85 Bn	₹41.02 Bn	₹46.13 Bn	CapitalWorkInProgress
Goodwill	N/A	N/A	N/A	N/A	₹161.36 Bn	₹163.72 Bn	₹167.86 Bn	₹183.78 Bn	Goodwill
Other Intangible Assets	N/A	N/A	N/A	N/A	₹57.96 Bn	₹68.53 Bn	₹64.69 Bn	₹86.36 Bn	OtherIntangibleAssets
Non-current Investments	N/A	N/A	N/A	N/A	₹6.04 Bn	₹6.84 Bn	₹6.80 Bn	₹10.89 Bn	NoncurrentInvestments
Other Non-current Assets	N/A	N/A	N/A	N/A	₹6.52 Bn	₹8.41 Bn	₹8.46 Bn	₹7.14 Bn	OtherNoncurrentAssets
Total Non-current Assets	N/A	N/A	N/A	N/A	₹397.09 Bn	₹408.92 Bn	₹425.11 Bn	₹464.71 Bn	NoncurrentAssets
Inventories	N/A	N/A	N/A	N/A	₹42.44 Bn	₹49.44 Bn	₹49.31 Bn	₹60.86 Bn	Inventories
Trade Receivables	N/A	N/A	N/A	N/A	₹35.73 Bn	₹62.31 Bn	₹54.88 Bn	₹59.87 Bn	TradeReceivablesCurrent
Cash and Cash Equivalents	N/A	N/A	N/A	N/A	₹13.23 Bn	₹12.34 Bn	₹32.27 Bn	₹24.16 Bn	CashAndCashEquivalents
Current Investments	N/A	N/A	N/A	N/A	₹13.27 Bn	₹3.16 Bn	₹4.47 Bn	₹6.90 Bn	CurrentInvestments
Other Current Assets	N/A	N/A	N/A	N/A	₹5.88 Bn	₹7.15 Bn	₹0.00 Bn	₹8.87 Bn	OtherCurrentAssets
Total Current Assets	N/A	N/A	N/A	N/A	₹123.34 Bn	₹151.79 Bn	₹162.86 Bn	₹171.80 Bn	CurrentAssets
Total Assets	N/A	N/A	N/A	N/A	₹520.43 Bn	₹560.71 Bn	₹587.97 Bn	₹636.51 Bn	Assets
Equity Share Capital	N/A	N/A	N/A	N/A	₹6.00 Bn	₹6.00 Bn	₹6.00 Bn	₹8.11 Bn	EquityShareCapital
Other Equity	N/A	N/A	N/A	N/A	₹172.67 Bn	₹191.83 Bn	₹210.44 Bn	₹332.21 Bn	OtherEquity
Equity Attributable to Owners	N/A	N/A	N/A	N/A	₹178.67 Bn	₹197.84 Bn	₹216.44 Bn	₹340.32 Bn	EquityAttributableToOwnersOfParent
Non-controlling Interests	N/A	N/A	N/A	N/A	₹46.22 Bn	₹54.91 Bn	₹60.69 Bn	₹25.90 Bn	NonControllingInterest
Total Equity	N/A	N/A	N/A	N/A	₹224.89 Bn	₹252.75 Bn	₹277.12 Bn	₹366.21 Bn	Equity
Long-term Borrowings	N/A	N/A	N/A	N/A	₹152.91 Bn	₹129.32 Bn	₹124.05 Bn	₹107.46 Bn	BorrowingsNoncurrent
Total Non-current Liabilities	N/A	N/A	N/A	N/A	₹210.43 Bn	₹154.37 Bn	₹167.51 Bn	₹129.60 Bn	NoncurrentLiabilities
Short-term Borrowings	N/A	N/A	N/A	N/A	₹24.80 Bn	₹27.97 Bn	₹53.50 Bn	₹40.78 Bn	BorrowingsCurrent
Trade Payables	N/A	N/A	N/A	N/A	₹39.83 Bn	₹62.72 Bn	₹65.49 Bn	₹67.72 Bn	TradePayablesCurrent
Other Current Liabilities	N/A	N/A	N/A	N/A	₹11.09 Bn	₹7.77 Bn	₹10.25 Bn	₹12.60 Bn	OtherCurrentLiabilities
Total Current Liabilities	N/A	N/A	N/A	N/A	₹85.11 Bn	₹153.59 Bn	₹143.34 Bn	₹140.69 Bn	CurrentLiabilities
Total Equity and Liabilities	N/A	N/A	N/A	N/A	₹520.43 Bn	₹560.71 Bn	₹587.97 Bn	₹636.51 Bn	EquityAndLiabilities

Every figure above is the exact value of the named XBRL element from BIOCON.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).